SECOND RESEARCH AGREEMENTSecond Research Agreement • August 18th, 2014 • Ohr Pharmaceutical Inc • Pharmaceutical preparations
Contract Type FiledAugust 18th, 2014 Company IndustryTHIS Second Research Agreement (this “Agreement”) is made and entered into effective as of July 30, 2013 (the “Effective Date”), by and between SKS Ocular, LLC, a Delaware limited liability company and its subsidiary, C Therapeutics, LLC, having a principal place of business at 57 Meadow Woods Road, Great Neck, New York 11020 (collectively “SKS”) and [redacted]*. SKS and [redacted] may be referred to in this Agreement individually as a “Party” or collectively as the “Parties.”